FDA Inspection 1287458 — Livent USA Corp

Livent USA Corp — FEI 1015213

The FDA completed an inspection of Livent USA Corp on September 11, 2025 in Bessemer City, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bessemer City, NC (United States)